Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...
Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...
Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.
Meet the Innovators of the Year for Senior Health honorees for Atlanta Business Chronicle's Health Care Champion Awards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback